AAN (AIDS ALLIANCE NEPAL) is a national community based non-profitorganization representing people living with HIV/AIDS through a network of individuals and groups who provide services to people living withHIV/AIDS (PLWHA). AAN was formed in March 2005 in response to an emerging need for PLWHA (especially women and children living with HIV) to be given a voice.
AAN Newsletter






fpan

Death March

No matter how serious a disease may be, devising a cure or treatment or ways of prevention is only half the battle. The other half can be more mysterious. Throughout the world, people who should know better eat, drink or have sex in needlessly risky ways, or ignore medical danger signs until it is too late. These, the willful ignorers, are what interest the South African journalist Jonny Steinberg about the gravest medical crisis his country has experienced: AIDS. More than one out of every eight South Africans is H.I.V. positive, Steinberg reports; every day roughly 800 South Africans die of AIDS and more than 1,000 additional people are infected. A recent survey found that in the previous month, the average South African was more than twice as likely to have been to a funeral as to a wedding.

By ADAM HOCHSCHILD
Published: February 10, 2008

 Oncology Biologics Development Primer

February 28-29, 2008
Gaithersburg Marriott Washingtonian Center
Gaithersburg, MD

The iSBTc Oncology Biologics Development Primer (OBDP) will be a key forum for continuing to explore and discuss best practices for worldwide biologics development. Through the expertise of the invited speakers, panel members, and attendees, this rigorous and challenging program curriculum will facilitate understanding, open discussion, and exploration of the development issues surrounding biologic agents for cancer.

iSBTc developed the OBDP to meet the needs of the biological therapy community by educating physicians and researchers on the worldwide regulatory paths for biological therapy development. Further, through facilitating collaborative interactions between regulators, preclinical scientists, clinical investigators and industry, the iSBTc Oncology Biologics Development Primer will help ensure that active, innovative new therapies are rapidly and appropriately moved into worldwide clinical testing.

Target Audience:
Physicians and scientists in academia, industry and regulatory agencies with an interest in the strategic, preclinical, clinical and regulatory aspects of efficient oncology biologics development.

Topics to be Addressed: 

  • Regulatory expectations in the US, EU, and Japan for oncology biologics therapeutics development
  • Preclinical development strategies
  • Clinical trial design and regulatory expectations
  • Good Clinical Practice (GCP) standards
  • Regulatory strategies in the US, EU, and Japan
  • Moving from bench to bedside
  • In-licensing and out-licensing expectations and opportunities for academia and industry

Meeting Goals:

  • Provide a framework for dissemination of information on best practices in pre-clinical testing and clinical trial design for those actively involved in the development of biologic oncology therapeutics.
  • Create a forum for dialogue among regulatory agencies, industry and academic investigators regarding efficient strategies for oncology biologics development.
  • Encourage and enhance strategic thinking for oncology biologic therapeutics development by case studies of preclinical and clinical development roadmap to achieve the desired goals.
  • Attendees will gain an understanding of the latest regulatory expectations and requirements in the development process for oncology biologic therapeutics.
                 

 

 

Microbicides 2008
24 to 27 February 2008
New Delhi, India

Website: http://www.microbicides2008.com
Contact name: Nomita Chandhiok

The conference intends to provide updates on the current state of art and the likely future scenario of ongoing research and development efforts in the area of microbicides, in different parts of the world.

Organized by: Indian Council of Medical Research
Deadline for abstracts/proposals: 30 September 2007 

 


 

SC orders secrecy in PLWHA related cases
KATHMANDU, Dec 26 - The Supreme Court on Tuesday ordered the government to enact laws that ensure secrecy in the judicial process for cases involving people living with HIV/AIDS (PLWHA) or sensitive issues of women and children. The apex court also said it would formulate a set of guidelines for courts and the government outlining how such cases should be dealt with in court until necessary new laws are enacted. The guidelines would be effective from January 24, 2008, the court ruled. The apex court, however, did not give details of the guidelines. Under existing law some sensitive cases concerning women and children are heard in camera but the whole judicial process is not kept secret. But today's order requires courts and the government to maintain secrecy throughout the judicial process from the time of filing of cases till after the verdicts are handed down. Justices Khil Raj Regmi and Kalyan Shrestha issued the order in response to public interest litigation brought by the Forum for Women, Law and Development, a women's rights NGO. Source: ekantipur